Neurology: Neuroimmunology & Neuroinflammation COVID-19 Articles
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis
Gertjan Peeters, Ann Van Remoortel, Guy Nagels, Jeroen Van Schependom, Miguel D'haeseleer
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases: COPANMO(G)-Study
Martin W. Hümmert, Franziska Bütow, Daria Tkachenko, et al.
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Anna G. Francis, Kariem Elhadd, Valentina Camera, et al.
Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year
Giulio Disanto, Alice Galante, Marco Cantu', et al.
Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment
Christina Woopen, Marie Dunsche, Rocco Haase, et al.
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Michael J. Peluso, Hannah M. Sans, Carrie A. Forman, et al.
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.
Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology
Marinos C. Dalakas, Josep Dalmau
Refractory Anti-NMDA Receptor Encephalitis in Early Pregnancy: A Case Report of Treatment Course and Pregnancy Outcomes
Sarah Fredrich, Cynthia Wang, Ram Narayan, Lauren Tardo, Kyle M. Blackburn, Steven Vernino
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection
Barbara A. Hanson, Lavanya Visvabharathy, Sareen T. Ali, et al.
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
Ana Zabalza, Georgina Arrambide, Paula Tagliani, et al.
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study
Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.
Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID
Anne Louise Oaklander, Alexander J. Mills, Mary Kelley, et al.
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
Afagh Garjani, Rodden M. Middleton, Richard Nicholas, Nikos Evangelou
Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine
Michael Yu Sy, Erin Fromm, Linda Doan, Nathan Rojek, Alexander Ulrich Brandt
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
Maria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
Farren Basil Shaw Briggs, Farrah J. Mateen, Hollie Schmidt, et al.
Impact of COVID-19 in Immunosuppressed Children With Neuroimmunologic Disorders
Gemma Olivé-Cirera, Elianet Fonseca, Verónica Cantarín-Extremera, et al.
COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series
Roseanne Sullivan, Ajay Kilaru, Bernhard Hemmer, et al.
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic
Martin S. Weber, Jacqueline A. Nicholas, Michael R. Yeaman
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders
Samira Luisa Apostolos-Pereira, Lis Campos Ferreira, Mateus Boaventura, et al.
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis
Giovanna S. Manzano, Caleb R. S. McEntire, Maria Martinez-Lage, Farrah J. Mateen, Spencer K. Hutto
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
Kévin Bigaut, Laurent Kremer, Thibaut Fabacher, et al.
CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection
Garrett M. Timmons, Torge Rempe, Elizabeth A. Bevins, et al.
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis
Kelli M. Money, Ashmanie Mahatoo, Soleil Samaan, et al.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation
Raphael Bernard-Valnet, Sylvain Perriot, Mathieu Canales, et al.
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
Georgina Arrambide, Miguel Ángel Llaneza-González, Lucienne Costa-Frossard França, et al.
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry
Scott D. Newsome, Anne H. Cross, Robert J. Fox, et al.
Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2
Mario Sa, Luwaiza Mirza, Michael Carter, et al.
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
Lara Diem, Christoph Friedli, Andrew Chan, Anke Salmen, Robert Hoepner
Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit
Maria Sepúlveda, Sara Llufriu, Eugenia Martínez-Hernández, et al.
Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19
Vidmante Fuchs, Michael Kutza, Sven Wischnewski, et al.
Biological Significance of Anti–SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy/strong>
Navid Manouchehri, Lawrence Steinman, Olaf Stuve
Presentations and mechanisms of CNS disorders related to COVID-19
Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
Harry Alexopoulos, Eleni Magira, Kleopatra Bitzogli et al.
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency
Steffen Pfeuffer, Matthias Pawlowski, Gunther S. Joos, et al.
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center
Erica Parrotta, Ilya Kister, Leigh Charvet, et al.
Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
Adil Maarouf, Audrey Rico, Clemence Boutiere, Marine Perriguey, Sarah Demortiere, Jean Pelletier, Bertrand Audoin, Under the aegis of OFSEP
COVID-19-associated ophthalmoparesis and hypothalamic involvement
Elba Pascual-Goñi, Juan Fortea, Alejandro Martínez-Domeño, et al.
Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis
Marta Bodro, Yaroslau Compta, Laura Llansó, et al.
CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19
Ashwin A. Pinto, Liam S. Carroll, Vijay Nar, Aravinthan Varatharaj, Ian Galea
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
Cole Maguire, Teresa Frohman, Scott S. Zamvil, Elliot Frohman, Esther Melamed
COVID-19-associated acute necrotizing myelitis
Javier Sotoca, Yensa Rodríguez-Álvarez
Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19
Ahmed Elkady, Alejandro A. Rabinstein
Acute disseminated encephalomyelitis after SARS-CoV-2 infection
Giovanni Novi, Tommaso Rossi, Enrico Pedemonte, et al.
COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia
Luke Dixon, James Varley, Anastassia Gontsarova, et al.
Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Moli Fan, Wei Qiu, Bitao Bu,et al.
Guillain-Barré syndrome related to SARS-CoV-2 infection
Kévin Bigaut, Martial Mallaret, Seyyid Baloglu, et al.
COVID-19 in MS: Initial observations from the Pacific Northwest
James D. Bowen, Justine Brink, Ted R. Brown, Elisabeth B. Lucassen, Kyle Smoot, Annette Wundes, Pavle Repovic
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease—More to come with myositis in the offing
Marinos C. Dalakas
COVID-19—White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
Gilles Brun, Jean-François Hak, Stéphanie Coze, et al.
COVID-19 and MS Disease-modifying Therapies
Joseph R. Berger, Rachel Brandstadter, Amit Bar-Or
COVID-19 Infection in a Patient With Multiple Sclerosis Treated With Fingolimod
Mahdi Barzegar, Omid Mirmosayyeb, Nasim Nehzat, et al.
Guillain-Barré syndrome related to COVID-19 infection
Paola Alberti, Simone Beretta, Marco Piatti, et al.
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken